Australian & New Zealand Society of Blood Transfusion
Australasian Society of Thrombosis & Haemostasis
Sydney Convention & Exhibition Centre, Darling Harbour, Sydney NSW, Australia
Keynote Speakers
A/Professor Lynn Boshkov, | |
 | Lynn Boshkov is Associate Professor of Pathology and Medicine, Oregon Health & Science University (OHSU), Portland Oregon, USA. She is also Director of Hemostasis & Thrombosis and Associate Director of Transfusion Medicine at OHSU. Previously she was Associate Professor of Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada. She trained at McGill University Medical School, Montreal Quebec. Her current active research interests are Transfusion-Related Acute Lung Injury (TRALI); leukodepletion and patient outcome; neonatal and paediatric coagulation, with special interest in the congenital cardiac population including heparin-induced thrombocytopenia and use of novel anticoagulants; and coagulation in critical care. |
Dr Kenneth J Clemetson, | |
 | Kenneth Clemetson has been at the Theodor Kocher Institute since December 1972 with Ernst Lüscher, and as Professor of Biochemistry since 1990. He received a PhD in organic chemistry (affinity-labelling with galactosides) from Christ's College/Department of Chemistry, University of Cambridge in 1968. His post-doctoral work was at the University of Alberta, Edmonton, Canada (1968-1970) and the University of California, Santa Barbara (1970-1972) on carbohydrate chemistry (antibiotic synthesis) and then its applications in biochemistry and microbiology.
Initially, his studies were on techniques for the isolation and characterisation of cell receptors and then with platelets from 1974. The highlights of his research career have been the isolation and characterisation of platelet receptors; platelet receptors in bleeding disorders; 2D separations of carbohydrate surface labelled platelets (early proteomics!); the first identification of several platelet receptor components; cloning GPVI; platelet receptor signalling; the crystal structure of GPIb; COAT platelets/role of serotonin; and snake venom proteins and platelet receptors. Clemetson was made a in 2002, and received a in 2003. Prizes/Honours: 1990 Mogens-Ellerman Prize of the Swiss Society of Haematology |
Dr Roger Dodd, | |
 | Roger Dodd was born in England and obtained his BSc in biochemistry at the University of Sheffield in 1964. He worked as a Scientific Officer in the Ministry of Defence (UK) for about six years, when he left for the United States to join the American Red Cross, where he has worked for the past 33 years. He rapidly developed his research interest in transfusion-transmitted infections. During that time, he obtained his PhD in Microbiology at the George Washington University in 1978. He is currently Executive Director, Blood Services Research and Development, and Head of the Transmissible Diseases Department at the Holland Laboratories and is responsible for the Red Cross research programs supporting its blood program. He has more than 130 publications and has edited three books on transfusion transmitted infections. He serves on the Editorial Boards of Transfusion and Transfusion Medicine Reviews and is a Past President of the American Association of Blood Banks. He has received the Morten Grove-Rasmussen and Emily Cooley Memorial Awards from the AABB, a Tiffany Award from the American Red Cross, and the John Snow award from the APHA. He is an Advisor to WHO and until recently served as Chair of the Global Collaboration on Blood Safety. |
Dr Jean-Marie Freyssinet, | |
 | Jean-Marie Freyssinet is Director of Research, INSERM, (Hôpital de Bicêtre) and affiliated with the Université Louis Pasteur, Strasbourg, France. He qualified at the Université Joseph Fourier, Grenoble. His major research interests are the study of the plasma membrane remodelling process in the procoagulant and pro-inflammatory responses, and apoptotic cell death; the search for candidate genes governing phosphatidylserine transmembrane migration or store-operated Ca2+ entry ; and the pathophysiologic significance of shed membrane microparticles (Unité 143 INSERM and Institut d'Hématologie et Immunologie, Université Louis Pasteur, Strasbourg, France). |
Dr Margaret A. Goodell, | |
 | Margaret A Goodell is an Associate Professor at the Center for Cell and Gene Therapy at Baylor College of Medicine in Houston, Texas. She received her PhD from Cambridge University in England, and performed post-doctoral work at MIT and Harvard Medical School. At Baylor, her laboratory works on mouse and human hematopoietic stem cells, focusing their mechanisms of regulation and their differentiation plasticity of stem cells in a variety of in vivo models. |
Professor Alois Gratwohl, | |
 | Professor Alois Gratwohl is Head of Hematology at the University Hospital in Basel and Professor for Hematology and Stem Cell Transplantation at the Medical Faculty of the University of Basel. He graduated from the Medical Faculties of the University of Geneva and Basel. He trained at the University Hospitals in Basel and the Pediatric Hematology Branch of the National Institutes of Health in Bethesda, USA. He has a longstanding interest in hematopoietic stem cell transplantation with focus on graft-versus-host disease, risk assessment and transplantation for autoimmune diseases.
He has served as President, Congress President, Chair of the Chronic Leukemia Working Party for the European Group for Blood and Marrow Transplantation (EBMT), as Board Member and Congress President of the European Hematology Association (EHA), President of the Swiss Society for Hematology and Swiss Society for Blood and Marrow Transplantation. He is involved in several other professional societies, including the American Society of Hematology, the International Bone Marrow Transplant Registry and World Marrow Donor Association. |
Ms Sandra Gray, | |
 | Sandra Gray is the program manager for the Effective Use of Blood (EUB) Group, Scottish National Blood Transfusion Service. The EUB group has a remit to promote clinical effectiveness in transfusion in NHSScotland. During this time Sandra developed the role of the transfusion nurse specialist in Scotland and led a 3-year study evaluating the role. The transfusion practitioner role has subsequently been implemented throughout NHS Scotland as part of the 3-year Better Blood Transfusion program. Professional interests include improving transfusion practice through the development of educational materials. Sandra is a member of the Serious Hazards of Transfusion Standing Working Group, RCN Blood Transfusion Forum, and currently chairs the British Blood Transfusion Society Professional Affairs and Education Committee, nursing sub-committee. |
Professor Michael J Keating, | |
 | Michael J Keating is a Professor of Medicine in Hematology at the MD Anderson Cancer Center. He has been a member of the faculty since 1977 and works as a physician in the Leukemia Department. In the earlier phases of his career, the importance of cytogenetics in predicting probability of response to treatment and survival in acute leukemia were foremost in his research interest. Since the mid-1980s chronic lymphocytic leukemia (CLL) has been the major focus of his research. The development of a new drug for treatment of CLL, called .udarabine, has continued as a major source of clinical research as this drug is now established as the most important single agent in CLL, and a major component of treatment of patients with low grade lymphoma, acute myelogenous leukemia, and myelodysplastic syndrome. His career is marked by close collaboration with laboratory scientists but his major focus has been on delivery of effective, compassionate care to patients suffering from leukemia. In 1988, Dr Keating won the Service to Mankind Award from the Leukemia Society of America and in 1996 was voted one of the best doctors in America by the American Health magazine. In January 2002, he was awarded the Charles A. LeMaistre Outstanding Achievement Award in Cancer and in March 2002, the Rai and Binet Award at the International Workshop on CLL. His major pursuits at the present time are developing new potentially curative therapies for CLL and developing rational combinations of new agents in the treatment of leukemia in general. |
Dr Thomas J. Kipps, | |
 | Thomas Kipps is a Professor in the Department of Medicine and Deputy Director of Research at the Moores UCSD Cancer Center. He was recently appointed as the holder of the Evelyn and Edwin Tasch Chair in Cancer Research. He is the Principal Investigator of the Chronic Lymphocytic Leukemia Research Consortium (CRC) a multi-site institutional basic and clinical research consortium developed to accelerate delivery of curative treatment strategies for patients with this disease. He received his BA in Biochemistry from Columbia College of Columbia University and his PhD and MD from Harvard Medical School. After receiving postdoctoral training at Stanford University Medical Center, he joined Scripps Clinic and Research Foundation at La Jolla. Here he became Co-Director of the Flow Cytometry Center of the Research Institute until 1990, when he joined UCSD.
Professor Kipps has a national and international reputation for his work in hematologic malignancies and has received a number of awards and honors, including the Henry Ashbury Christian Award of Harvard University for excellence in scholarship and research, and the Stohlman Memorial Scholar Award from the Leukemia Society of America. He has published more than 150 articles in peer-reviewed journals, authored a number of book chapters and is on the editorial board of several journals. |
Dr Agnes Lee, | |
 | Agnes Lee is an Associate Professor in the Department of Medicine at McMaster University. She is a consultant in the Thrombosis Service at the Hamilton Health Sciences Henderson Hospital and is active in clinical trials research. She completed her training in internal medicine at the University of British Columbia and her training in haematology at McMaster University. She has a Masters degree in Health Research Methodology and currently holds a New Investigator Award from the Canadian Institutes of Health Research/Rx&D Research Program and was a recipient of Research Fellowships from the Heart and Stroke Scientific Research Corporation of Canada and the Heart and Stroke Foundation of Canada.
Dr Lee's research interest is in thrombotic disease in high-risk populations, with a focus on venous thromboembolism in patients with malignancy. She is the co-principal investigator of the CLOT in Cancer* trial, an international study that compared the efficacy and safety of low-molecular-weight heparin with oral anticoagulant therapy for the prevention of recurrent venous thromboembolism in cancer patients. She is also involved in translational research exploring the role of coagulation in cancer biology. Her research activities include studies in catheter-related thrombosis, diagnosis deep vein thrombosis and pulmonary embolism in pregnant women, and thromboprophylaxis in patients undergoing major orthopedic surgery. |
Dr Kit Lin, | |
 | Dr C K Lin is currently the Hospital Chief Executive of the Hong Kong Red Cross Blood Transfusion Service and the Human Resources Service Director of Kowloon Central Cluster, Hospital Authority, Hong Kong. He has been the honorary advisor to the Blood Programme of China Red Cross since 1993. Dr Lin is a graduate of the Medical School in University of Hong Kong. He obtained the Fellowship of the Royal College of Pathologists, Australasia in 1989, Fellowship of the Hong Kong College of Pathologists in 1991, Fellowship of the Hong Kong College of Community Medicine and MBA, University of Birmingham, in 2000. Dr Lin has published many papers in transfusion medicine in various international journals. |
Dr Lewis R Silverman, | |
 | Lewis Silverman is an Associate Professor of Medicine and Director of the Myelodysplastic Syndrome and Myeloproliferative Disease Program, Mount Sinai School of Medicine, in New York City. His subspeciality training was in Hematology at Montefiore Medical Center, in the Albert Einstein College of Medicine and then subsequently received training in Oncology at the Mount Sinai School of Medicine, both in New York. Dr Silverman was awarded the National Service Research Award Fellowship from the National Cancer Institute and the Distinguished Research Award for Creative and Innovative Investigations and Inspired Mentoring of Young Biomedical Scientists from the Samuel Bronfman Department of Medicine, Mount Sinai School of Medicine. He is an experienced investigator in the area of haematologic malignancies and has served as Principal Investigator for several national clinical trials exploring treatments for patients with the Myelodysplastic Syndrome. He served as Principal Investigator of the randomised Phase III trial of Azacitidine vs. Supportive Care which served as the basis for approval of Azacitidine by the FDA for MDS in the United States. |
Dr Jill Storry, | |
 | Jill Storry is currently a post-doctoral fellow in the Department of Transfusion Medicine, Lund University, Sweden. Born in Zimbabwe, she started her Medical Technology training in Harare before moving to Bristol, England. There, she completed her training and a MSc in Applied Immunology and moved to the USA to join the American Red Cross National Reference Laboratory. Jill obtained her PhD while working at the New York Blood Center Immunohematology Reference Laboratory. Jill is a recipient of the British Blood Transfusion Society's Race and Sanger Award and has authored over 30 papers on serological and molecular aspects of blood groups. |
Dr Ayalew Tefferi, | |
 | Dr Ayalew Tefferi was born in Addis Ababa, Ethiopia and migrated to the United States in 1982 after completing his medical school education at the University of Athens in Athens, Greece. Dr Tefferi received his Hematology training at the Mayo Clinic in Rochester, MN before joining the staff at the Mayo Clinic College of Medicine, Division of Hematology in the Department of Medicine. He is currently a full professor in Hematology and Internal Medicine.
Dr Tefferi spends the majority of his time in direct patient care and his clinical as well as laboratory interests focus on chronic myeloproliferative disorders, myelodysplastic syndrome, chronic myeloid leukemia, hypereosinophilic syndrome, and systemic mast cell disease. His academic and research achievements have been copious and include over 600 publications including books, book chapters, original articles, reviews, editorials, letters, and abstracts. In addition, Dr Tefferi serves as an associate editor for both the Mayo Clinic Proceedings and the European Journal of Hematology, as well as being on the editorial board for Blood and several other Hematology journals. Dr Tefferi has given more than 300 national and international invited lectureships and serves as faculty for the annual Hematology and Oncology Board review courses at George Washington University in Washington DC, Harvard in Boston MA, and MD Anderson Cancer Center in Houston TX. |
Professor Pier Luigi Zinzani, | |
 | Pier Luigi Zinzani is Associate Professor of Hematology at the Institute of Hematology and Medical Oncology "L. e A. Seràgnoli" at the University of Bologna. He is a member of the Italian Society of Hematology, the Italian Society of Experimental Hematology, the American Society of Hematology and American Society of Clinical Oncology and has presented his research at more than 70 national and international meetings. He has written more than 190 refereed articles in journals such as Blood, the Journal of Clinical Oncology and Annals of Oncology. His current research interest includes clinical trial methodology, prognostic factors in NHL, Hodgkin's disease, chronic lymphocytic leukemia, new drugs development, and hairy cell leukemia. |
Local Invited Speakers
Dr Peter Bardy Ms Robyn Barlow Dr Ali Bianchi Dr Tim Brighton Dr Vivien Chen Dr Jenny Curnow Prof Michael Friedlander Prof Peter George Ms Nicky Gilroy A/Prof David Gottlieb Prof Bob Graham Dr Sally Greenaway Prof David Handelsman Prof Steve Henry A/Prof Tim Hughes Dr James Ibister A/Prof Peter Illingworth A/Prof Chris Jackson Ms Fiona Jolly Dr Joanne Joseph Dr David Joske A/Prof Surender Juneja Ms Tracey King Ms Katrina Lewis Catherine McGrath Dr Maria Makrides Dr Lars Nielsen Dr Peter O'Brien Dr Miriam O'Connor Ms Carol O'Shea Prof Martin Pera A/Prof Tony Schwarer A/Prof Paul Simmons Moira Stephens Prof Geoffrey Tofler Ms Rosita van Kuilenberg Prof Marcus Vowels Dr Chris Ward Prof Jim Wiley Dr Ross Wilson A/Prof Graham Young
Festival City Conventions
PO Box 949
Kent Town SA 5071
Australia
Tel: +61 8 8363 1307
Fax: +61 8 8363 1604
haa2005@fcconventions.com.au
Monday, 5 December 2005, 19:46:03
http://www.fcconventions.com.au/HAA2005/speakers.html